Health Condition 1: N915- Oligomenorrhea, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: I. Married/ Unmarried Women aged 18-35 years II. Diagnosed with PCOS based on Rotterdam criteria (2 out of 3 symptoms if present)
Exclusion criteria
Exclusion criteria: I. Patients below 18 years and above 35 years. II. Intake of any testosterone level modifying drugs in the 3 months prior to study inclusion. III. Female participants who are ovariectomized, hysterectomized or post-menopausal IV. Pregnant or lactating women V. Potentially severe immunosuppression or intake of other immunosuppressive drugs VI. Other clinically significant concomitant disease states (e.g., renal failure, active carcinoma), and women with other endocrine disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of the clinical outcomes of PCOS with improving menstrual regularity.Timepoint: 12 WEEKS | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in free testosterone level. Improvement in Ovarian Volume. Improvement in weight evidence by BMI & improvement in body fat distribution by waist circumference (WC) hip circumference (HC) & waist/hip ratio. Timepoint: 12 WEEKS | — |
Countries
Sri Lanka
Contacts
Bandaranayake Memorial Ayurveda Research Institute